TXLNB
gene geneOn this page
Also known as DKFZp451A175MDP77dJ522B19.2
Summary
TXLNB (taxilin beta, HGNC:21617) is a protein-coding gene on chromosome 6q24.1, encoding Beta-taxilin (Q8N3L3). Promotes motor nerve regeneration.
Predicted to enable syntaxin binding activity. Located in cytoplasm.
Source: NCBI Gene 167838 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 75 total
- MANE Select transcript:
NM_153235
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21617 |
| Approved symbol | TXLNB |
| Name | taxilin beta |
| Location | 6q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp451A175, MDP77, dJ522B19.2 |
| Ensembl gene | ENSG00000164440 |
| Ensembl biotype | protein_coding |
| OMIM | 611438 |
| Entrez | 167838 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding_CDS_not_defined, 2 protein_coding, 1 nonsense_mediated_decay
ENST00000358430, ENST00000367652, ENST00000715942, ENST00000715943, ENST00000715944, ENST00000715945
RefSeq mRNA: 1 — MANE Select: NM_153235
NM_153235
CCDS: CCDS34545
Canonical transcript exons
ENST00000358430 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001421552 | 139240061 | 139243314 |
| ENSE00001422744 | 139291921 | 139291998 |
| ENSE00001431226 | 139288476 | 139288913 |
| ENSE00004028407 | 139276830 | 139276921 |
| ENSE00004028408 | 139247817 | 139247909 |
| ENSE00004028409 | 139262579 | 139262773 |
| ENSE00004028413 | 139260318 | 139260437 |
| ENSE00004028415 | 139244595 | 139244690 |
| ENSE00004028417 | 139255564 | 139255638 |
| ENSE00004028420 | 139270456 | 139270626 |
Expression profiles
Bgee: expression breadth ubiquitous, 187 present calls, max score 98.94.
FANTOM5 (CAGE): breadth broad, TPM avg 4.4094 / max 620.9152, expressed in 596 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 75948 | 3.7844 | 518 |
| 75947 | 0.2933 | 64 |
| 75949 | 0.2091 | 62 |
| 75950 | 0.0609 | 33 |
| 75946 | 0.0550 | 20 |
| 75943 | 0.0068 | 2 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| vastus lateralis | UBERON:0001379 | 98.94 | gold quality |
| quadriceps femoris | UBERON:0001377 | 98.80 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 98.80 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 98.19 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.15 | gold quality |
| biceps brachii | UBERON:0001507 | 98.14 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 97.97 | gold quality |
| deltoid | UBERON:0001476 | 96.53 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.33 | gold quality |
| muscle of leg | UBERON:0001383 | 95.93 | gold quality |
| muscle tissue | UBERON:0002385 | 95.50 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 94.88 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 94.40 | gold quality |
| body of tongue | UBERON:0011876 | 94.34 | gold quality |
| tibialis anterior | UBERON:0001385 | 93.60 | gold quality |
| myocardium | UBERON:0002349 | 93.53 | gold quality |
| heart right ventricle | UBERON:0002080 | 91.78 | gold quality |
| heart left ventricle | UBERON:0002084 | 91.13 | gold quality |
| cardiac ventricle | UBERON:0002082 | 91.07 | gold quality |
| cardiac atrium | UBERON:0002081 | 90.10 | gold quality |
| apex of heart | UBERON:0002098 | 90.06 | gold quality |
| right atrium auricular region | UBERON:0006631 | 89.87 | gold quality |
| heart | UBERON:0000948 | 87.20 | gold quality |
| tongue | UBERON:0001723 | 84.78 | gold quality |
| bronchial epithelial cell | CL:0002328 | 78.77 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.66 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 77.41 | gold quality |
| bronchus | UBERON:0002185 | 77.05 | gold quality |
| calcaneal tendon | UBERON:0003701 | 74.85 | gold quality |
| left ovary | UBERON:0002119 | 74.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
141 targeting TXLNB, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
Literature-anchored findings (GeneRIF, showing 1)
- identification of isoforms of taxilin; interaction with syntaxin; tissue distribution [beta-taxilin, gamma-taxilin]. (PMID:15184072)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | txlnba | ENSDARG00000020594 |
| danio_rerio | txlnbb | ENSDARG00000076241 |
| mus_musculus | Txlnb | ENSMUSG00000039891 |
| rattus_norvegicus | Txlnb | ENSRNOG00000060021 |
| drosophila_melanogaster | CG5886 | FBGN0039379 |
| caenorhabditis_elegans | T22C1.6 | WBGENE00011917 |
Paralogs (2): TXLNA (ENSG00000084652), TXLNG (ENSG00000086712)
Protein
Protein identifiers
Beta-taxilin — Q8N3L3 (reviewed: Q8N3L3)
Alternative names: Muscle-derived protein 77
All UniProt accessions (2): Q8N3L3, H7BY59
UniProt curated annotations — full annotation on UniProt →
Function. Promotes motor nerve regeneration. May be involved in intracellular vesicle traffic.
Subunit / interactions. Binds to the C-terminal coiled coil region of syntaxin family members STX1A, STX3A and STX4A. Has a preference for STX1A.
Tissue specificity. Expressed in skeletal muscle.
Similarity. Belongs to the taxilin family.
RefSeq proteins (1): NP_694967* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026183 | Taxilin_fam | Family |
Pfam: PF09728
UniProt features (21 total): compositionally biased region 6, region of interest 4, sequence variant 4, modified residue 2, sequence conflict 2, coiled-coil region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N3L3-F1 | 68.83 | 0.37 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 474, 483
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 101 (showing top):
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP, TATTATA_MIR374, GOMF_SYNTAXIN_BINDING, GOMF_SNARE_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, F10_TARGET_GENES, TERF1_TARGET_GENES, ZIM3_TARGET_GENES, ZNF169_TARGET_GENES, ZNF2_TARGET_GENES, ZNF843_TARGET_GENES, MIR153_5P, MIR7_1_3P
GO Biological Process (0):
GO Molecular Function (2): syntaxin binding (GO:0019905), protein binding (GO:0005515)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| SNARE binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
708 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TXLNB | STX8 | Q9UNK0 | 763 |
| TXLNB | STX7 | O15400 | 719 |
| TXLNB | STX3 | Q13277 | 718 |
| TXLNB | STX4 | Q12846 | 707 |
| TXLNB | STX1A | Q16623 | 647 |
| TXLNB | TMEM236 | Q5W0B7 | 627 |
| TXLNB | CCDC158 | Q5M9N0 | 516 |
| TXLNB | CIMAP3 | Q8TCI5 | 473 |
| TXLNB | RNF122 | Q9H9V4 | 470 |
| TXLNB | SYBU | Q9NX95 | 462 |
| TXLNB | IGSF5 | Q9NSI5 | 458 |
| TXLNB | ZFYVE26 | Q68DK2 | 447 |
| TXLNB | CDHR3 | Q6ZTQ4 | 442 |
| TXLNB | PRPF6 | O94906 | 438 |
| TXLNB | SHISA6 | Q6ZSJ9 | 434 |
IntAct
292 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TXLNB | TXLNA | psi-mi:“MI:0915”(physical association) | 0.880 |
| TXLNA | TXLNB | psi-mi:“MI:0915”(physical association) | 0.880 |
| TXLNB | KRT38 | psi-mi:“MI:0915”(physical association) | 0.830 |
| LURAP1 | TXLNB | psi-mi:“MI:0915”(physical association) | 0.830 |
| TXLNB | LURAP1 | psi-mi:“MI:0915”(physical association) | 0.830 |
| KRT38 | TXLNB | psi-mi:“MI:0915”(physical association) | 0.830 |
| CEP70 | TXLNB | psi-mi:“MI:0915”(physical association) | 0.780 |
| TXLNB | DEUP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| DEUP1 | TXLNB | psi-mi:“MI:0915”(physical association) | 0.720 |
| TXLNB | CCDC196 | psi-mi:“MI:0915”(physical association) | 0.720 |
| VIM | TXLNB | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT15 | TXLNB | psi-mi:“MI:0915”(physical association) | 0.720 |
| TXLNB | NMI | psi-mi:“MI:0915”(physical association) | 0.720 |
| TXLNB | USHBP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| NMI | TXLNB | psi-mi:“MI:0915”(physical association) | 0.720 |
| DYDC1 | TXLNB | psi-mi:“MI:0915”(physical association) | 0.720 |
BioGRID (132): TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid)
ESM2 similar proteins: A1L260, A2AMM0, A2VDA9, A5PJI6, B1PRL5, O35867, O54724, O75410, O94876, O95810, P85125, Q13625, Q2T9X8, Q3U1C4, Q53HC0, Q5BKX8, Q5RBY6, Q5RDH2, Q5RKG1, Q5T1M5, Q63918, Q66H98, Q69ZZ6, Q6AYB8, Q6INU2, Q6IRU7, Q6NRH3, Q6NTW1, Q6NZI2, Q6P9Q6, Q6ZPJ0, Q7TNY7, Q7ZWE6, Q80U16, Q80Z25, Q86YF9, Q8BHS8, Q8BMD2, Q8C804, Q8CG79
Diamond homologs: P40222, Q6GVM5, Q6PAM1, Q8BHN1, Q8N3L3, Q8VBT1, Q9BZA5, Q9I969, Q9NUQ3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 71 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Formation of the cornified envelope | 11 | 24.2× | 9e-11 |
| Loss of Nlp from mitotic centrosomes | 5 | 19.8× | 2e-04 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 5 | 19.8× | 2e-04 |
| AURKA Activation by TPX2 | 5 | 19.0× | 2e-04 |
| Recruitment of mitotic centrosome proteins and complexes | 5 | 17.0× | 3e-04 |
| Regulation of PLK1 Activity at G2/M Transition | 5 | 15.9× | 4e-04 |
| Keratinization | 11 | 15.3× | 7e-09 |
| Recruitment of NuMA to mitotic centrosomes | 5 | 14.6× | 5e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| morphogenesis of an epithelium | 10 | 59.3× | 1e-13 |
| intermediate filament organization | 13 | 54.0× | 3e-17 |
| epithelial cell differentiation | 9 | 27.2× | 5e-09 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
75 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 65 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1653 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:139244588:T:TA | donor_gain | 1.0000 |
| 6:139244590:CTCA:C | donor_loss | 1.0000 |
| 6:139244591:TCA:T | donor_loss | 1.0000 |
| 6:139244592:CAC:C | donor_loss | 1.0000 |
| 6:139244594:CCT:C | donor_gain | 1.0000 |
| 6:139244686:GTTGT:G | acceptor_gain | 1.0000 |
| 6:139244687:TTGT:T | acceptor_gain | 1.0000 |
| 6:139244688:TGT:T | acceptor_gain | 1.0000 |
| 6:139244688:TGTC:T | acceptor_loss | 1.0000 |
| 6:139244690:TC:T | acceptor_loss | 1.0000 |
| 6:139244691:C:CC | acceptor_gain | 1.0000 |
| 6:139244691:CTACA:C | acceptor_loss | 1.0000 |
| 6:139244692:T:G | acceptor_loss | 1.0000 |
| 6:139247809:ATACT:A | donor_loss | 1.0000 |
| 6:139247811:ACT:A | donor_loss | 1.0000 |
| 6:139247812:CTC:C | donor_loss | 1.0000 |
| 6:139247812:CTCA:C | donor_gain | 1.0000 |
| 6:139247813:TCAC:T | donor_loss | 1.0000 |
| 6:139247814:CACTT:C | donor_loss | 1.0000 |
| 6:139247815:A:AC | donor_gain | 1.0000 |
| 6:139247815:ACTTT:A | donor_loss | 1.0000 |
| 6:139247816:C:CG | donor_gain | 1.0000 |
| 6:139247816:CT:C | donor_gain | 1.0000 |
| 6:139247816:CTT:C | donor_gain | 1.0000 |
| 6:139247816:CTTT:C | donor_gain | 1.0000 |
| 6:139247816:CTTTG:C | donor_gain | 1.0000 |
| 6:139247905:GTGAG:G | acceptor_gain | 1.0000 |
| 6:139247906:TGAG:T | acceptor_gain | 1.0000 |
| 6:139247907:GAG:G | acceptor_gain | 1.0000 |
| 6:139247908:AG:A | acceptor_gain | 1.0000 |
AlphaMissense
4520 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:139262616:A:G | L282P | 1.000 |
| 6:139262628:A:G | L278P | 1.000 |
| 6:139260386:C:G | A312P | 0.999 |
| 6:139260394:A:G | L309P | 0.999 |
| 6:139260400:T:G | Q307P | 0.999 |
| 6:139260406:A:G | L305P | 0.999 |
| 6:139260433:A:G | L296P | 0.999 |
| 6:139262626:C:G | A279P | 0.999 |
| 6:139262649:A:G | L271P | 0.999 |
| 6:139262661:C:G | R267P | 0.999 |
| 6:139262700:A:G | L254P | 0.999 |
| 6:139262712:A:G | F250S | 0.999 |
| 6:139270481:A:G | L221P | 0.999 |
| 6:139270487:C:G | R219P | 0.999 |
| 6:139270511:C:G | R211P | 0.999 |
| 6:139243247:C:G | R445P | 0.998 |
| 6:139247866:A:G | L374P | 0.998 |
| 6:139247908:A:G | L360P | 0.998 |
| 6:139260371:C:G | A317P | 0.998 |
| 6:139260379:A:G | L314P | 0.998 |
| 6:139262586:C:A | R292I | 0.998 |
| 6:139262598:T:G | Q288P | 0.998 |
| 6:139262616:A:T | L282Q | 0.998 |
| 6:139262628:A:T | L278H | 0.998 |
| 6:139262636:G:C | N275K | 0.998 |
| 6:139262636:G:T | N275K | 0.998 |
| 6:139262637:T:A | N275I | 0.998 |
| 6:139262638:T:C | N275D | 0.998 |
| 6:139262711:G:C | F250L | 0.998 |
| 6:139262711:G:T | F250L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000014570 (6:139182436 G>GTT), RS1000015718 (6:139198003 C>T), RS1000040674 (6:139216630 A>G), RS1000040893 (6:139170304 C>G,T), RS1000041574 (6:139287812 C>T), RS1000045130 (6:139260907 C>T), RS1000050518 (6:139266519 T>C), RS1000054403 (6:139177312 G>A,C,T), RS1000068165 (6:139325186 G>A,T), RS1000094964 (6:139288177 A>G), RS1000107501 (6:139217057 A>G), RS1000112450 (6:139168793 T>C), RS1000139642 (6:139261280 C>A), RS1000179439 (6:139268586 T>C), RS1000190101 (6:139164320 G>A)
Disease associations
OMIM: gene MIM:611438 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005240_1 | Caudate volume in trauma-exposed individuals | 2.000000e-07 |
| GCST005956_33 | Waist-to-hip ratio adjusted for BMI | 6.000000e-09 |
| GCST005962_46 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 6.000000e-08 |
| GCST005987_41 | Albumin-globulin ratio | 8.000000e-11 |
| GCST005990_57 | Non-albumin protein levels | 2.000000e-10 |
| GCST006979_399 | Heel bone mineral density | 2.000000e-12 |
EFO canonical traits (7, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004830 | caudate nucleus volume |
| EFO:0008483 | response to trauma exposure |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0005128 | albumin:globulin ratio measurement |
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs9495425 | TXLNB | 0.00 | 0 |
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 3 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| sodium arsenite | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | increases expression, increases response to substance | 1 |
| incobotulinumtoxinA | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Triclosan | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.